HELP Committee Supports Reauthorizing FDA Program to Streamline Review of OTC Drugs

(MedPage Today) — Lawmakers expressed bipartisan support for reauthorizing an FDA program that helps streamline the process for bringing nonprescription drugs to market during a hearing of the Senate Health, Education, Labor, and Pensions (HELP…

Source link : https://www.medpagetoday.com/washington-watch/washington-watch/115912

Author :

Publish date : 2025-06-04 20:51:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

HELP Committee Supports Reauthorizing FDA Program to Streamline Review of OTC Drugs

Texas Hospital That Discharged Woman With Doomed Pregnancy Violated Law, Probe Finds

SGLT2 Inhibitor Shows Promise as MASH Treatment

Related Posts

Drugmaker Refuses FDA’s Request to Pull Gene Therapy Tied to Patient Deaths

How to buy the right sports bra for you

X-Ray Rib Counting Unreliable for Neonates’ Lung Volume?

Forest Green football tickets on prescription under new scheme

Higher BMI, Bigger Gains: Tirzepatide’s Effects on HFpEF

Anticoagulants in AF Post-ICH: The Dilemma Continues

Drugmaker Refuses FDA’s Request to Pull Gene Therapy Tied to Patient Deaths

How to buy the right sports bra for you

X-Ray Rib Counting Unreliable for Neonates’ Lung Volume?

Forest Green football tickets on prescription under new scheme

Higher BMI, Bigger Gains: Tirzepatide’s Effects on HFpEF

Anticoagulants in AF Post-ICH: The Dilemma Continues

Man Pulled Into MRI Dies; Trump Budget Would Stall New Drugs; Allergy-Free Amish

Foundations Rethink Research Dollars as Funding Is Pulled

Categories

Archives